Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 12—December 2024
Research

Cost-effectiveness Analysis of Japanese Encephalitis Vaccination for Children <15 Years of Age, Bangladesh

An Nguyen1, Rebeca Sultana1Comments to Author , Elisabeth Vodicka, Zareen Tasnim, Kamran Mehedi, Md. Monjurul Islam, S.M. Abdullah Al Murad, Md. Redowan Ullah, Sharmin Sultana, Tahmina Shirin, and Clint Pecenka
Author affiliation: Program for Appropriate Technology in Health (PATH), Ho Chi Minh City, Vietnam (A. Nguyen); icddr,b, Dhaka, Bangladesh (R. Sultana, Z. Tasnim, M.R. Ullah); PATH, Seattle, Washington, USA (E. Vodicka, C. Pecenka); PATH, Dhaka (K. Mehedi); Maternal, Newborn, Child and Adolescent Health, Dhaka (M.M. Islam, S.M.A. Al Murad); Institute of Epidemiology Diseases Control and Research, Dhaka (S. Sultana, T. Shirin)

Main Article

Table 3

Discounted incremental outcomes and program costs of different Japanese encephalitis vaccination strategies as compared with no vaccination from the governmental payer and societal perspectives in Bangladesh

Discounted incremental outcomes Routine immunization birth cohorts Strategy 1, subnational campaign + subnational routine* Strategy 2, subnational campaign + national routine† Strategy 3, national routine‡
Cases averted
 10 5,733 8,962 5,663
20
 7,544
 13,176
 9,876
DALYs averted
 10 58,130 91,104 57,829
20
 76,624
 134,134
 100,859
Deaths averted
 10 1,147 1,792 1,133
20
 1,509
 2,635
 1,975
Total vaccinated
 10 30,337,406 45,866,646 27,234,783
20
 42,042,950
 73,101,429
 54,469,566
Discounted vaccine program costs, $§
 10 57.1M 95.5M 67.3M
20
 82.2M
 154.0M
 125.8M
*Subnational 1-time immunization campaign for children <15 years of age and subnational routine immunization for 9-month-old children. The subnational approach focuses on 3 divisions with a high number of JE cases: Rangpur, Rajshahi, and Chattogram.
†Subnational 1-time immunization campaign and national routine immunization.
‡S3, national routine immunization only.
§US dollars.

Main Article

1These first authors contributed equally to this article.

Page created: August 29, 2024
Page updated: November 26, 2024
Page reviewed: November 26, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external